BACKGROUND: Patients with pneumococcal meningitis often die or have severe neurological damage despite optimal antibiotic therapy. New or improved therapy is required. The delivery of new interventions will require an improved understanding of the disease pathogenesis. Our objective was to learn more about the pathophysiology of severe meningitis through the interpretation of differences in the proteomic profile of cerebrospinal fluid (CSF) from patients with meningitis. METHODS: Two-dimensional polyacrylamide gel electrophoresis of CSF from normal subjects (controls, n = 10) and patients with pneumococcal meningitis (n = 20) was analyzed. Spot differences were compared and identified between controls, nonsurvivors (n = 9), and survivors (n = 11). RESULTS: Protein concentration in CSF of patients with meningitis was 4-fold higher than in CSF of control subjects (7.0 mg/mL vs 0.23 mg/mL; P < .01). A mean of 2466 discrete protein spots was present in CSF of patients with meningitis. Thirty-four protein spots were differentially expressed in CSF of nonsurvivors, compared with survivors. None of these protein spots were observed in CSF of control subjects. CONCLUSIONS: Proteomic screening of CSF yields potential biomarkers capable of differentiating control subjects from nonsurvivors and survivors of meningitis. Proteins involved in the inflammatory process and central metabolism were represented in the differentially expressed protein repertoire.
BACKGROUND:Patients with pneumococcal meningitis often die or have severe neurological damage despite optimal antibiotic therapy. New or improved therapy is required. The delivery of new interventions will require an improved understanding of the disease pathogenesis. Our objective was to learn more about the pathophysiology of severe meningitis through the interpretation of differences in the proteomic profile of cerebrospinal fluid (CSF) from patients with meningitis. METHODS: Two-dimensional polyacrylamide gel electrophoresis of CSF from normal subjects (controls, n = 10) and patients with pneumococcal meningitis (n = 20) was analyzed. Spot differences were compared and identified between controls, nonsurvivors (n = 9), and survivors (n = 11). RESULTS: Protein concentration in CSF of patients with meningitis was 4-fold higher than in CSF of control subjects (7.0 mg/mL vs 0.23 mg/mL; P < .01). A mean of 2466 discrete protein spots was present in CSF of patients with meningitis. Thirty-four protein spots were differentially expressed in CSF of nonsurvivors, compared with survivors. None of these protein spots were observed in CSF of control subjects. CONCLUSIONS: Proteomic screening of CSF yields potential biomarkers capable of differentiating control subjects from nonsurvivors and survivors of meningitis. Proteins involved in the inflammatory process and central metabolism were represented in the differentially expressed protein repertoire.
Authors: Gregor Zysk; Gesina Bethe; Roland Nau; Daniela Koch; Valeska C D H Gräfin Von Bassewitz; Hans-Peter Heinz; Ralf R Reinert Journal: J Infect Dis Date: 2002-12-19 Impact factor: 5.226
Authors: Sang Min Jung; Kibeom Lee; Joung Wook Lee; Hong Namkoong; Hyun Kee Kim; Sanghee Kim; Hae Ri Na; Seon-Ah Ha; Jae-Ryong Kim; Jesang Ko; Jin Woo Kim Journal: Neurosci Lett Date: 2008-03-18 Impact factor: 3.046
Authors: Thomas E Angel; Jon M Jacobs; Robert P Smith; Mark S Pasternack; Susan Elias; Marina A Gritsenko; Anil Shukla; Edward C Gilmore; Carol McCarthy; David G Camp; Richard D Smith; H Shaw Warren Journal: J Proteome Res Date: 2012-08-31 Impact factor: 4.466
Authors: Emma C Wall; Stephen B Gordon; Samia Hussain; Upali R S Goonetilleke; Jenna Gritzfeld; Matthew Scarborough; Aras Kadioglu Journal: Clin Infect Dis Date: 2012-01-11 Impact factor: 9.079
Authors: James M Njunge; Ian N Oyaro; Nelson K Kibinge; Martin K Rono; Symon M Kariuki; Charles R Newton; James A Berkley; Evelyn N Gitau Journal: Wellcome Open Res Date: 2017-09-26
Authors: Emma C Wall; Jenna F Gritzfeld; Matthew Scarborough; Katherine M B Ajdukiewicz; Mavuto Mukaka; Caroline Corless; David G Lalloo; Stephen B Gordon Journal: J Infect Date: 2014-06-26 Impact factor: 6.072
Authors: Uri Obolski; Andrea Gori; José Lourenço; Craig Thompson; Robin Thompson; Neil French; Robert S Heyderman; Sunetra Gupta Journal: Sci Rep Date: 2019-03-11 Impact factor: 4.379